Literature DB >> 19587035

Insight into poliovirus genome replication and encapsidation obtained from studies of 3B-3C cleavage site mutants.

Hyung Suk Oh1, Harsh B Pathak, Ian G Goodfellow, Jamie J Arnold, Craig E Cameron.   

Abstract

A poliovirus (PV) mutant (termed GG), which is incapable of producing 3AB, VPg, and 3CD proteins due to a defective cleavage site between the 3B and 3C proteins, replicated, producing 3BC-linked RNA rather than the VPg-linked RNA produced by the wild type (WT). GG PV RNA is quasi-infectious. The yield of infectious GG PV relative to replicated RNA is reduced by almost 5 logs relative to that of WT PV. Proteolytic activity required for polyprotein processing is normal for the GG mutant. 3BC-linked RNA can be encapsidated as efficiently as VPg-linked RNA. However, a step after genome replication but preceding virus assembly that is dependent on 3CD and/or 3AB proteins limits production of infectious GG PV. This step may involve release of replicated genomes from replication complexes. A pseudorevertant (termed EG) partially restored cleavage at the 3B-3C cleavage site. The reduced rate of formation of 3AB and 3CD caused corresponding reductions in the observed rate of genome replication and infectious virus production by EG PV without impacting the final yield of replicated RNA or infectious virus relative to that of WT PV. Using EG PV, we showed that genome replication and encapsidation were distinct steps in the multiplication cycle. Ectopic expression of 3CD protein reversed the genome replication phenotype without alleviating the infectious-virus production phenotype. This is the first report of a trans-complementable function for 3CD for any picornavirus. This observation supports an interaction between 3CD protein and viral and/or host factors that is critical for genome replication, perhaps formation of replication complexes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19587035      PMCID: PMC2738245          DOI: 10.1128/JVI.02076-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  85 in total

1.  Poliovirus requires a precise 5' end for efficient positive-strand RNA synthesis.

Authors:  J Herold; R Andino
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Identification of a cis-acting replication element within the poliovirus coding region.

Authors:  I Goodfellow; Y Chaudhry; A Richardson; J Meredith; J W Almond; W Barclay; D J Evans
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Effect of cordycepin on the replication of western equine encephalitis virus.

Authors:  K Hashimoto; B Simizu
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

4.  cis-acting lesions targeted to the hydrophobic domain of a poliovirus membrane protein involved in RNA replication.

Authors:  C Giachetti; S S Hwang; B L Semler
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

5.  Poliovirus 2C region functions during encapsidation of viral RNA.

Authors:  L M Vance; N Moscufo; M Chow; B A Heinz
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

6.  Site-directed mutagenesis of the putative catalytic triad of poliovirus 3C proteinase.

Authors:  T Hämmerle; C U Hellen; E Wimmer
Journal:  J Biol Chem       Date:  1991-03-25       Impact factor: 5.157

7.  Intracellular location and translocation of silent and active poliovirus replication complexes.

Authors:  Denise Egger; Kurt Bienz
Journal:  J Gen Virol       Date:  2005-03       Impact factor: 3.891

8.  Cellular origin and ultrastructure of membranes induced during poliovirus infection.

Authors:  A Schlegel; T H Giddings; M S Ladinsky; K Kirkegaard
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

9.  Independent replication of cowpea mosaic virus bottom component RNA: in vivo instability of the viral RNAs.

Authors:  A D Varennes; A J Maule
Journal:  Virology       Date:  1985-07-30       Impact factor: 3.616

10.  Purification and characterization of hepatitis C virus non-structural protein 5A expressed in Escherichia coli.

Authors:  Luyun Huang; Elena V Sineva; Michele R S Hargittai; Suresh D Sharma; Mehul Suthar; Kevin D Raney; Craig E Cameron
Journal:  Protein Expr Purif       Date:  2004-09       Impact factor: 1.650

View more
  19 in total

Review 1.  Expanding knowledge of P3 proteins in the poliovirus lifecycle.

Authors:  Craig E Cameron; Hyung Suk Oh; Ibrahim M Moustafa
Journal:  Future Microbiol       Date:  2010-06       Impact factor: 3.165

Review 2.  The genome-linked protein VPg of vertebrate viruses - a multifaceted protein.

Authors:  Ian Goodfellow
Journal:  Curr Opin Virol       Date:  2011-10-07       Impact factor: 7.090

3.  A Polymerase mechanism-based strategy for viral attenuation and vaccine development.

Authors:  Spencer A Weeks; Cheri A Lee; Yan Zhao; Eric D Smidansky; Avery August; Jamie J Arnold; Craig E Cameron
Journal:  J Biol Chem       Date:  2012-08-01       Impact factor: 5.157

Review 4.  Initiation of protein-primed picornavirus RNA synthesis.

Authors:  Aniko V Paul; Eckard Wimmer
Journal:  Virus Res       Date:  2015-01-12       Impact factor: 3.303

5.  Novel roles of the picornaviral 3D polymerase in viral pathogenesis.

Authors:  Jason Kerkvliet; Ramakrishna Edukulla; Moses Rodriguez
Journal:  Adv Virol       Date:  2010-01-01

6.  Direct interaction between two viral proteins, the nonstructural protein 2C and the capsid protein VP3, is required for enterovirus morphogenesis.

Authors:  Ying Liu; Chunling Wang; Steffen Mueller; Aniko V Paul; Eckard Wimmer; Ping Jiang
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

7.  Poliovirus infection transiently increases COPII vesicle budding.

Authors:  Meg Trahey; Hyung Suk Oh; Craig E Cameron; Jesse C Hay
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

8.  RNA virus population diversity, an optimum for maximal fitness and virulence.

Authors:  Victoria K Korboukh; Cheri A Lee; Ashley Acevedo; Marco Vignuzzi; Yinghong Xiao; Jamie J Arnold; Stephen Hemperly; Jason D Graci; Avery August; Raul Andino; Craig E Cameron
Journal:  J Biol Chem       Date:  2014-09-11       Impact factor: 5.157

9.  Allosteric inhibitors of Coxsackie virus A24 RNA polymerase.

Authors:  Catherine H Schein; Diane Rowold; Kyung H Choi
Journal:  Bioorg Med Chem       Date:  2015-12-15       Impact factor: 3.641

10.  CsrA activates flhDC expression by protecting flhDC mRNA from RNase E-mediated cleavage.

Authors:  Alexander V Yakhnin; Carol S Baker; Christopher A Vakulskas; Helen Yakhnin; Igor Berezin; Tony Romeo; Paul Babitzke
Journal:  Mol Microbiol       Date:  2013-01-11       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.